Close Menu

SIRS-Lab

NEW YORK (GenomeWeb News) – Analytik Jena said today it has acquired all the assets of SIRS-Lab, a developer of molecular diagnostics for infectious diseases, which declared ins

NEW YORK (GenomeWeb News) – SIRS-Lab, a German molecular diagnostic developer, said today that it has begun insolvency proceedings and it is seeking an investor to commercialize its leading product, a test for the causative agent of sepsis.

Becton Dickinson said this week that its BD MAX MRSA molecular test has received a CLIA moderate complexity rating.

German molecular diagnostics firm SIRS-Lab this week commenced a 1,000-patient clinical study in its home country to evaluate Vyoo, the company's PCR- and microarray-based molecular test for causative agents of sepsis. Results from the study will support an application for regulatory approval in Europe.

The initial focus of the partnership will be on using molecular diagnostics to test for severe fungal blood stream infections and to evaluate the clinical impact and pharmacoeconomics of such an approach.

Roche gets FDA nod for dual-PCR HIV viral load test; Cepheid wins approval for S. aureus test; Viracor-IBT Labs launches Aspergillus PCR panel; SIRS-Lab, Analytik Jena partner on sepsis diagnostics

Analytik Jena's subsidiary will provide SIRS-Lab an instrument and associated reagents for a sepsis test currently undergoing a clinical study.

Science reports that a new White House Office of Management and Budget memo rescinds previous ones that helped research institutions deal with pandemic-related closures.

Researchers report on a concerning strain of the H1N1 swine flu virus found among pigs in China, Agence France Presse reports.

The Associated Press reports that US officials are considering allowing pooled COVID-19 testing.

In Genome Research this week: Y chromosome gene expression analysis, de novo mutations rise with paternal age in rhesus macaques, and more.